These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6167377)

  • 1. Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.
    Mirabelli CK; Crooke ST
    Cancer Chemother Pharmacol; 1981; 5(4):251-6. PubMed ID: 6167377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin.
    Mirabelli CK; Huang CH; Fenwick RG; Crooke ST
    Antimicrob Agents Chemother; 1985 Apr; 27(4):460-7. PubMed ID: 2408562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b.
    Mistry JS; Jani JP; Morris G; Mujumdar RB; Reynolds IJ; Sebti SM; Lazo JS
    Cancer Res; 1992 Feb; 52(3):709-18. PubMed ID: 1370650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the sequences at specific sites on DNA cleaved by the antitumor antibiotics talisomycin and bleomycin.
    Mirabelli CK; Beattie WG; Huang CH; Prestayko AW; Crooke ST
    Cancer Res; 1982 Apr; 42(4):1399-404. PubMed ID: 6174223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the cytostatic effect of bleomycin on L5178y mouse lymphoma cells by pepleomycin.
    Müller WE; Geisert M; Zahn RK; Maidhof A; Bachmann M; Umezawa H
    Eur J Cancer Clin Oncol; 1983 May; 19(5):665-70. PubMed ID: 6191987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships involved in the site-specific fragmentation of linear duplex DNAs by talisomycin and bleomycin analogs.
    Mirabelli CK; Huang CH; Prestayko AW; Crooke ST
    Cancer Chemother Pharmacol; 1982; 8(1):57-65. PubMed ID: 6178526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity to bleomycin of human cultured tumor cells and analysis of related factors].
    Urade M; Sugi M; Shirasuna K; Sugiyama M; Miyazaki T
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2382-8. PubMed ID: 6195972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High induction of poly(ADP-ribose) polymerase activity in bleomycin-resistant HeLa cells.
    Urade M; Sugi M; Mima T; Ogura T; Matsuya T
    Jpn J Cancer Res; 1989 May; 80(5):464-8. PubMed ID: 2473971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of combined treatments with low hyperthermia and bleomycin on survivals of murine L cells.
    Shioura H; Hayashi S; Matsumoto H; Kitai R; Ohtsubo T; Nishida T; Zhang SW; Yoshida M; Ishii Y; Kano E
    J Exp Clin Cancer Res; 1997 Jun; 16(2):147-52. PubMed ID: 9261739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin resistance in mammalian cells expressing a genetic suppressor element derived from the SRPK1 gene.
    Sanz G; Mir L; Jacquemin-Sablon A
    Cancer Res; 2002 Aug; 62(15):4453-8. PubMed ID: 12154054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tallysomycin biosynthetic gene cluster from Streptoalloteichus hindustanus E465-94 ATCC 31158 unveiling new insights into the biosynthesis of the bleomycin family of antitumor antibiotics.
    Tao M; Wang L; Wendt-Pienkowski E; George NP; Galm U; Zhang G; Coughlin JM; Shen B
    Mol Biosyst; 2007 Jan; 3(1):60-74. PubMed ID: 17216057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tallysomycin S10b: experimental antitumor activity and toxicity.
    Schurig JE; Rose WC; Hirth RS; Schlein A; Huftalen JB; Florczyk AP; Bradner WT
    Cancer Chemother Pharmacol; 1984; 13(3):164-70. PubMed ID: 6207948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle phase recovery from bleomycin-induced potentially lethal damage.
    Barranco SC; Bolton WE
    Cancer Res; 1977 Aug; 37(8 Pt 1):2589-91. PubMed ID: 68809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms Enhancing the Cytotoxic Effects of Bleomycin plus Suicide or Interferon-β Gene Lipofection in Metastatic Human Melanoma Cells.
    Fondello C; Agnetti L; Glikin GC; Finocchiaro LME
    Anticancer Agents Med Chem; 2018; 18(9):1338-1348. PubMed ID: 29866016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermla cell kinetics in hairless mice after bleomycin. I. Perturbations after different single doses.
    Thorud E; Clausen OP
    Cancer Treat Rep; 1978 Mar; 62(3):351-61. PubMed ID: 77187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
    Urade M; Sugi M; Matsuya T
    Jpn J Cancer Res; 1988 Apr; 79(4):491-500. PubMed ID: 2454906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal breakage correlates with delayed lethality in normal and ataxia telangiectasia cell lines treated with bleomycin.
    MacLeod RA; Buchheim T; Kaufmann M; Drexler HG
    Mutat Res; 1996 Nov; 372(1):33-42. PubMed ID: 9003529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs.
    Mirabelli CK; Huang CH; Crooke ST
    Cancer Res; 1980 Nov; 40(11):4173-7. PubMed ID: 6162546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.